Search Diabetes In Control

Cast Your Vote

In a recent study, Victoza lowered A1c by 1.5% and Bydureon by 1.3%. Will this affect your recommendations?

Diabetes In Control Advertisers

Cast Your Vote

Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

View All Polls »

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:

CME/CE of the Week

Basic Management of Diabetic Foot Infections

John Steinberg, DPM

Category: Diabetic Foot
Credits: .75

Featured Jobs

Outpatient Physician - Onward Md
West Palm Beach, Florida

Physician, Endocrinologist - HCA
Mcallen, Texas

Assistant Director of Nursing - Signature Healthcare
Port Charlotte, Florida

Diabetes Educator - Saint Louis University Hospital
St. Louis, Missouri

Assistant Chief Pharmacist, GS-660-12 - Indian Health Service
Rosebud, South Dakota

Health Promotion Registered Dietitian, - Quarterline
Clovis, New Mexico

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control

Privacy / Advertising With Us / Contact Us

Entries (RSS News)

Add us to your favorite news reader

DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.